반응식
[C:1]1([CH3:14])[CH:6]=[C:5]([CH3:7])[CH:4]=[C:3]([CH3:8])[C:2]=1[N:9]1[CH:13]=[CH:12][N:11]=[CH:10]1.[Cl:15][CH2:16][C:17](=[O:22])[C:18]([CH3:21])([CH3:20])[CH3:19]>C1COCC1>[Cl-:15].[CH3:19][C:18]([CH3:21])([CH3:20])[C:17](=[O:22])[CH2:16][N+:11]1[CH:12]=[CH:13][N:9]([C:2]2[C:3]([CH3:8])=[CH:4][C:5]([CH3:7])=[CH:6][C:1]=2[CH3:14])[CH:10]=1참가 물질
4
실험 절차
According to the general synthesis procedure, 5.4 mmol (1.00 g) 1-mesitylimidazole and 6.4 mmol (0.870 g, 0.85 ml) 1-chloro-3,3-dimethyl-2-butanone are dissolved in 5 ml THF and heated for 45 min to 90° C.
후처리
- temperatureheated for 45 min to 90° C.
출처 및 근거
- ORD 기록
- ord-e2e7e09c5fa24ceb9ab565b4b33dba98
- 출처 데이터셋
- uspto-grants-2016_02
- 특허 번호
- US09260397B2
연결된 노트
불러오는 중…